_id
69171c2a3c536f8df2316672
Ticker
TCBPY
Name
TC Biopharm (Holdings) Plc
Exchange
PINK
Address
Maxim 1, Motherwell, United Kingdom, ML1 4WR
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://tcbiopharm.com
Description
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections, as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Last Close
0.07
Volume
2966
Current Price
0.1001
Change
-0.0191
Last Updated
2026-01-07T12:52:46.675Z
Image
-
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-06-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2054751
Operating Income
-2054751
Interest Expense
-
Pretax Income
-2092339
Net Income
-1986553
Eps
-0.01606875597198412
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-37588
Cash
1004329
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
3952319
Property Plant Equipment
2313870
Total Assets
6871395
Payables
942267
Short Term Debt
-
Long Term Debt
-
Total Liabilities
4867208
Equity
2004187
Bs_currency_symbol
GBP
Depreciation
120578
Change In Working Capital
-990840
Cash From Operations
-2732757
Capital Expenditures
30063
Cash From Investing
-
Cash From Financing
2786194
Net Change In Cash
23374
Cf_currency_symbol
GBP
PE
-
PB
6.174669793836603
ROE
-99.1201419827591
ROA
-28.910475965942865
FCF
-2762820
Fcf Percent
-
Piotroski FScore
0
Health Score
20
Deep Value Investing Score
1.5
Defensive Investing Score
4.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
5
Net Net Investing Score
2
Quality Investing Score
1.5
Value Investing Score
3.5
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2054751
Quarters > 0 > income Statement > operating Income
-2054751
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2092339
Quarters > 0 > income Statement > net Income
-1986553
Quarters > 0 > income Statement > eps
-0.01606875597198412
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
123628301
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-37588
Quarters > 0 > income Statement > currency_symbol
GBP
Quarters > 0 > balance Sheet > cash
1004329
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
3952319
Quarters > 0 > balance Sheet > property Plant Equipment
2313870
Quarters > 0 > balance Sheet > total Assets
6871395
Quarters > 0 > balance Sheet > payables
942267
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4867208
Quarters > 0 > balance Sheet > equity
2004187
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-1986553
Quarters > 0 > cash Flow > depreciation
120578
Quarters > 0 > cash Flow > change In Working Capital
-990840
Quarters > 0 > cash Flow > cash From Operations
-2732757
Quarters > 0 > cash Flow > capital Expenditures
30063
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2786194
Quarters > 0 > cash Flow > net Change In Cash
23374
Quarters > 0 > cash Flow > currency_symbol
GBP
Quarters > 0 > ratios > PE
-0.01606875597198412
Quarters > 0 > ratios > PB
6.174669793836603
Quarters > 0 > ratios > ROE
-99.1201419827591
Quarters > 0 > ratios > ROA
-28.910475965942865
Quarters > 0 > ratios > FCF
-2762820
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2024-03-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
3441656
Quarters > 1 > income Statement > operating Income
-3441656
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3432596
Quarters > 1 > income Statement > net Income
-3321854
Quarters > 1 > income Statement > eps
-0.04158643784874693
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
79878301
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
9060
Quarters > 1 > income Statement > currency_symbol
GBP
Quarters > 1 > balance Sheet > cash
980955
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
4202780
Quarters > 1 > balance Sheet > property Plant Equipment
2452761
Quarters > 1 > balance Sheet > total Assets
7264053
Quarters > 1 > balance Sheet > payables
1927612
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6183565
Quarters > 1 > balance Sheet > equity
1080488
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-4208340
Quarters > 1 > cash Flow > depreciation
127021
Quarters > 1 > cash Flow > change In Working Capital
13131
Quarters > 1 > cash Flow > cash From Operations
-2408593
Quarters > 1 > cash Flow > capital Expenditures
5618
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
932557
Quarters > 1 > cash Flow > net Change In Cash
-1481654
Quarters > 1 > cash Flow > currency_symbol
GBP
Quarters > 1 > ratios > PE
-0.04158643784874693
Quarters > 1 > ratios > PB
7.400191330306305
Quarters > 1 > ratios > ROE
-307.44015666994915
Quarters > 1 > ratios > ROA
-45.730035284709516
Quarters > 1 > ratios > FCF
-2414211
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2023-06-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
3519887
Quarters > 2 > income Statement > operating Income
-3519887
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
688493
Quarters > 2 > income Statement > net Income
988493
Quarters > 2 > income Statement > eps
0.1499021951387064
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
6594253
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
4351635
Quarters > 2 > income Statement > currency_symbol
GBP
Quarters > 2 > balance Sheet > cash
1918522
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4949230
Quarters > 2 > balance Sheet > property Plant Equipment
2680431
Quarters > 2 > balance Sheet > total Assets
8229408
Quarters > 2 > balance Sheet > payables
953855
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6222337
Quarters > 2 > balance Sheet > equity
2007071
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
988493
Quarters > 2 > cash Flow > depreciation
258812
Quarters > 2 > cash Flow > change In Working Capital
307018
Quarters > 2 > cash Flow > cash From Operations
-3640358
Quarters > 2 > cash Flow > capital Expenditures
71593
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
43811
Quarters > 2 > cash Flow > net Change In Cash
-3668140
Quarters > 2 > cash Flow > currency_symbol
GBP
Quarters > 2 > ratios > PE
0.1499021951387064
Quarters > 2 > ratios > PB
0.32887960879311195
Quarters > 2 > ratios > ROE
49.25052476967681
Quarters > 2 > ratios > ROA
12.01171457290731
Quarters > 2 > ratios > FCF
-3711951
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
63
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
12767670
Annuals > 0 > income Statement > operating Income
-12767670
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-12806001
Annuals > 0 > income Statement > net Income
-12154030
Annuals > 0 > income Statement > eps
-0.004882414893778146
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
2489348051
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-38331
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
1215640
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5774651
Annuals > 0 > balance Sheet > property Plant Equipment
2087624
Annuals > 0 > balance Sheet > total Assets
8328537
Annuals > 0 > balance Sheet > payables
1393325
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5318914
Annuals > 0 > balance Sheet > equity
3009623
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-12154030
Annuals > 0 > cash Flow > depreciation
434269
Annuals > 0 > cash Flow > change In Working Capital
-2026818
Annuals > 0 > cash Flow > cash From Operations
-12567288
Annuals > 0 > cash Flow > capital Expenditures
92514
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
11464634
Annuals > 0 > cash Flow > net Change In Cash
-1246969
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.004882414893778146
Annuals > 0 > ratios > PB
58.64348352464744
Annuals > 0 > ratios > ROE
-403.8389525864203
Annuals > 0 > ratios > ROA
-145.93235282499194
Annuals > 0 > ratios > FCF
-12659802
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
17
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
14239323
Annuals > 1 > income Statement > operating Income
-14239323
Annuals > 1 > income Statement > interest Expense
83025
Annuals > 1 > income Statement > pretax Income
-6995682
Annuals > 1 > income Statement > net Income
-5906953
Annuals > 1 > income Statement > eps
-0.22972980961481546
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
25712610
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
7326666
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
2462609
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5700927
Annuals > 1 > balance Sheet > property Plant Equipment
2615567
Annuals > 1 > balance Sheet > total Assets
8931664
Annuals > 1 > balance Sheet > payables
1847279
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6246434
Annuals > 1 > balance Sheet > equity
2685230
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-5906953
Annuals > 1 > cash Flow > depreciation
633008
Annuals > 1 > cash Flow > change In Working Capital
1539714
Annuals > 1 > cash Flow > cash From Operations
-10544870
Annuals > 1 > cash Flow > capital Expenditures
208789
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
8520376
Annuals > 1 > cash Flow > net Change In Cash
-2345451
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.22972980961481546
Annuals > 1 > ratios > PB
0.678907970266979
Annuals > 1 > ratios > ROE
-219.97940586095046
Annuals > 1 > ratios > ROA
-66.1349665639012
Annuals > 1 > ratios > FCF
-10753659
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
19
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3844532
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
15928529
Annuals > 2 > income Statement > operating Income
-12083997
Annuals > 2 > income Statement > interest Expense
6753231
Annuals > 2 > income Statement > pretax Income
-3033601
Annuals > 2 > income Statement > net Income
-1313601
Annuals > 2 > income Statement > eps
-0.6022540496006448
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2181141
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-314.31646296610353
Annuals > 2 > income Statement > total Other Income Expense Net
15803627
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
4808060
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
7447516
Annuals > 2 > balance Sheet > property Plant Equipment
3291445
Annuals > 2 > balance Sheet > total Assets
11291977
Annuals > 2 > balance Sheet > payables
882364
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
10960712
Annuals > 2 > balance Sheet > equity
331265
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-1736200
Annuals > 2 > cash Flow > depreciation
769596
Annuals > 2 > cash Flow > change In Working Capital
-6704967
Annuals > 2 > cash Flow > cash From Operations
-15292297
Annuals > 2 > cash Flow > capital Expenditures
365197
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
18653214
Annuals > 2 > cash Flow > net Change In Cash
3241372
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.6022540496006448
Annuals > 2 > ratios > PB
0.46682534194677977
Annuals > 2 > ratios > ROE
-396.54083588667686
Annuals > 2 > ratios > ROA
-11.633047074042038
Annuals > 2 > ratios > FCF
-15657494
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-4.072665801715267
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1978659
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
9259302
Annuals > 3 > income Statement > operating Income
-7280643
Annuals > 3 > income Statement > interest Expense
3438548
Annuals > 3 > income Statement > pretax Income
-14983467
Annuals > 3 > income Statement > net Income
-13575925
Annuals > 3 > income Statement > eps
-27.780239006323026
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
488690
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-367.95845064763563
Annuals > 3 > income Statement > total Other Income Expense Net
-4264309
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
1566688
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
3855840
Annuals > 3 > balance Sheet > property Plant Equipment
3684179
Annuals > 3 > balance Sheet > total Assets
8023596
Annuals > 3 > balance Sheet > payables
1422393
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
24582645
Annuals > 3 > balance Sheet > equity
-16559049
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-16610500
Annuals > 3 > cash Flow > depreciation
1025058
Annuals > 3 > cash Flow > change In Working Capital
-232079
Annuals > 3 > cash Flow > cash From Operations
-5581022
Annuals > 3 > cash Flow > capital Expenditures
143224
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
6525138
Annuals > 3 > cash Flow > net Change In Cash
800892
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-27.780239006323026
Annuals > 3 > ratios > PB
-0.002092397999426175
Annuals > 3 > ratios > ROE
81.9849316225829
Annuals > 3 > ratios > ROA
-169.20000707912013
Annuals > 3 > ratios > FCF
-5724246
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-2.892992678374596
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.01606875597198412
Valuation > metrics > PB
6.174669793836603
Valuation > final Score
20
Valuation > verdict
105.8% Overvalued
Profitability > metrics > ROE
-99.1201419827591
Profitability > metrics > ROA
-50.262972194299095
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.4285198936027426
Risk > metrics > Interest Coverage
-54.66507928062148
Risk > final Score
-201
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.19447884729063
Liquidity > metrics > Quick Ratio
4.19447884729063
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
90
Prev Valuations > 2
0
Prev Profitabilities > 0
15
Prev Profitabilities > 1
85
Prev Profitabilities > 2
0
Prev Risks > 0
-1513
Prev Risks > 1
3
Prev Risks > 2
0
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
0
Updated At
2026-01-20T22:40:24.233Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-05-09
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-40.36
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-40.36
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-09-30
Earnings History > 1 > report Date
2024-11-25
Earnings History > 1 > date
2024-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-79.73
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-79.73
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-08-28
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-121.1266
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-03-31
Earnings History > 3 > report Date
2024-05-29
Earnings History > 3 > date
2024-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-447.2059
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections, as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATC BioPharm Limited Enters Administration Amid Asset Sale Exploration TipRanks
Read more →TC BioPharm to be delisted from Nasdaq, moves to OTC Markets Investing.com
Read more →(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of TC Biopharm (Holdings) Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-40.36
EPS Estimate
0
EPS Difference
-40.36
Surprise Percent
0%
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.